These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23081796)

  • 1. The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination.
    Zahid MN; Turek M; Xiao F; Thi VL; Guérin M; Fofana I; Bachellier P; Thompson J; Delang L; Neyts J; Bankwitz D; Pietschmann T; Dreux M; Cosset FL; Grunert F; Baumert TF; Zeisel MB
    Hepatology; 2013 Feb; 57(2):492-504. PubMed ID: 23081796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein.
    Catanese MT; Graziani R; von Hahn T; Moreau M; Huby T; Paonessa G; Santini C; Luzzago A; Rice CM; Cortese R; Vitelli A; Nicosia A
    J Virol; 2007 Aug; 81(15):8063-71. PubMed ID: 17507483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.
    Rhainds D; Brodeur M; Lapointe J; Charpentier D; Falstrault L; Brissette L
    Biochemistry; 2003 Jun; 42(24):7527-38. PubMed ID: 12809509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.
    Zeisel MB; Koutsoudakis G; Schnober EK; Haberstroh A; Blum HE; Cosset FL; Wakita T; Jaeck D; Doffoel M; Royer C; Soulier E; Schvoerer E; Schuster C; Stoll-Keller F; Bartenschlager R; Pietschmann T; Barth H; Baumert TF
    Hepatology; 2007 Dec; 46(6):1722-31. PubMed ID: 18000990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.
    Voisset C; Callens N; Blanchard E; Op De Beeck A; Dubuisson J; Vu-Dac N
    J Biol Chem; 2005 Mar; 280(9):7793-9. PubMed ID: 15632171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of scavenger receptor class B type I in hepatitis C virus entry: kinetics and molecular determinants.
    Catanese MT; Ansuini H; Graziani R; Huby T; Moreau M; Ball JK; Paonessa G; Rice CM; Cortese R; Vitelli A; Nicosia A
    J Virol; 2010 Jan; 84(1):34-43. PubMed ID: 19828610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins.
    Maillard P; Huby T; Andréo U; Moreau M; Chapman J; Budkowska A
    FASEB J; 2006 Apr; 20(6):735-7. PubMed ID: 16476701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis.
    Trigatti BL; Krieger M; Rigotti A
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1732-8. PubMed ID: 12920050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scavenger receptor class B type I mediates the selective uptake of high-density lipoprotein-associated cholesteryl ester by the liver in mice.
    Brundert M; Ewert A; Heeren J; Behrendt B; Ramakrishnan R; Greten H; Merkel M; Rinninger F
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):143-8. PubMed ID: 15528479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.
    Dreux M; Pietschmann T; Granier C; Voisset C; Ricard-Blum S; Mangeot PE; Keck Z; Foung S; Vu-Dac N; Dubuisson J; Bartenschlager R; Lavillette D; Cosset FL
    J Biol Chem; 2006 Jul; 281(27):18285-95. PubMed ID: 16675450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling by the high-affinity HDL receptor scavenger receptor B type I.
    Saddar S; Mineo C; Shaul PW
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):144-50. PubMed ID: 20089950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation.
    Dao Thi VL; Dreux M; Cosset FL
    Expert Rev Mol Med; 2011 Apr; 13():e13. PubMed ID: 21489334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single amino acid mutation of SR-BI decreases infectivity of hepatitis C virus derived from cell culture in a cell culture model.
    Gao R; Gao W; Xu G; Xu J; Ren H
    World J Gastroenterol; 2017 Jul; 23(28):5158-5166. PubMed ID: 28811710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes.
    Barth H; Cerino R; Arcuri M; Hoffmann M; Schürmann P; Adah MI; Gissler B; Zhao X; Ghisetti V; Lavezzo B; Blum HE; von Weizsäcker F; Vitelli A; Scarselli E; Baumert TF
    J Virol; 2005 May; 79(9):5774-85. PubMed ID: 15827192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies.
    Bartosch B; Verney G; Dreux M; Donot P; Morice Y; Penin F; Pawlotsky JM; Lavillette D; Cosset FL
    J Virol; 2005 Jul; 79(13):8217-29. PubMed ID: 15956567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.
    Dreux M; Dao Thi VL; Fresquet J; Guérin M; Julia Z; Verney G; Durantel D; Zoulim F; Lavillette D; Cosset FL; Bartosch B
    PLoS Pathog; 2009 Feb; 5(2):e1000310. PubMed ID: 19229312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.
    Haberstroh A; Schnober EK; Zeisel MB; Carolla P; Barth H; Blum HE; Cosset FL; Koutsoudakis G; Bartenschlager R; Union A; Depla E; Owsianka A; Patel AH; Schuster C; Stoll-Keller F; Doffoël M; Dreux M; Baumert TF
    Gastroenterology; 2008 Nov; 135(5):1719-1728.e1. PubMed ID: 18718838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scavenger receptor class B, type I: a promising immunotherapy target.
    Fioravanti J; Medina-Echeverz J; Berraondo P
    Immunotherapy; 2011 Mar; 3(3):395-406. PubMed ID: 21395381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral load.
    Westhaus S; Deest M; Nguyen ATX; Stanke F; Heckl D; Costa R; Schambach A; Manns MP; Berg T; Vondran FWR; Sarrazin C; Ciesek S; von Hahn T
    J Hepatol; 2017 Aug; 67(2):237-245. PubMed ID: 28363797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scavenger receptor class B type I mediates cell entry of hepatitis C virus.
    Jia ZS; Du DW; Lei YF; Wei X; Yin W; Ma L; Lian JQ; Wang PZ; Li D; Zhou YX
    J Int Med Res; 2008; 36(6):1319-25. PubMed ID: 19094442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.